$277.22+24.35 (+9.63%)
Bloom Energy Corporation designs, manufactures, sells, and installs solid oxide fuel cell systems for on-site power generation in the United States and internationally.
Bloom Energy Corporation in the Industrials sector is trading at $277.22 with a market capitalization of $60.8B. Wall Street consensus targets $276.05 (26 analysts), implying a -0.4% move over the next 12 months. The stock is currently 21% below its 52-week high of $351.28, remaining 44.3% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.07Bβ | $751.05Mβ | $777.68Mβ | $519.05Mβ | $401.24M |
| Gross Profit | $355.57Mβ | $225.54Mβ | $239.90Mβ | $151.68Mβ | $107.12M |
| Operating Income | $182.24Mβ | $72.19Mβ | $87.53Mβ | $7.85Mβ | -$3.50M |
| Net Income | $196.29Mβ | $70.65Mβ | $1.09Mβ | -$23.09Mβ | -$42.62M |
Bloom Energy Corporation designs, manufactures, sells, and installs solid oxide fuel cell systems for on-site power generation in the United States and internationally. It offers Bloom Energy Server, an energy server platform to convert fuel, such as...

Stocks fell Tuesday as oil prices and Treasury yields rose, but AMD and HPE led AI plays flashing buy signals. An Apple iPhone event is on tap.
The S&P 500 is set for another shakeup, with Bloom Energy (BE), Everpure (P), and Illumina (ILMN) all joining in the next quarterly rebalancing near the end of September.

Shares of electricity generation and hydrogen production company Bloom Energy (NYSE:BE) jumped 11.2% in the afternoon session after news that the company will join the S&P 500 index on September 21.

Bloom Energy (BE) stock returned about 361% in the year from September 4, 2025, moving from roughly $55 to roughly $253. The power shortage behind that run was not what set Bloom apart from everyone else selling into it. The sign worth having sat in Bloom's own disclosures, and it was about speed.

βοΈ Amgen (AMGN): Shares of the biotechnology company, a major contributor to the Dow, shed 10%, its sharpest drop in 25 years. The move came after the Swiss drugmaker Novartis (CH:NOVN) said late Friday that an experimental medicine failed to reduce cardiovascular risk in a late-stage clinical trial.